FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for FETZIMA (levomilnacipran hydrochloride) from Allergan, Inc., authorizing a change to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• FETZIMA (levomilnacipran hydrochloride)

Snippet

SUPPL AP for FETZIMA (LEVOMILNACIPRAN HYDROCHLORIDE)